Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:48 PM
Ignite Modification Date:
2025-12-24 @ 4:48 PM
NCT ID:
NCT00195650
Eligibility Criteria:
Inclusion Criteria
* Participant was in a prior D2E7 (adalimumab) study
* Participant was age 18 or older and in good health (Investigator discretion) with a recent stable medical history.
Exclusion Criteria
* Participant was considered by the investigator, for any reason, to be an unsuitable candidate for the study
* Participant was a female subject who is pregnant or breast-feeding or considering becoming pregnant
* Participant had any ongoing chronic or active infection
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00195650
Study Brief:
Protocol Section:
NCT00195650